Core Viewpoint - Huajian Medical (01931) is acquiring approximately 1.848 billion shares of Guofu Quantum, representing 20.31% of its total issued share capital, for about HKD 3.142 billion, positioning Huajian Medical as the largest single shareholder of Guofu Quantum [1] Group 1 - The acquisition is a key move for Huajian Medical to advance its strategy of establishing a Real World Asset (RWA) tokenization exchange [1] - Huajian Medical possesses extensive resources in the medical industry, while its exchange offers a technology platform and trading venue for asset tokenization [1] - Guofu Quantum has strong capabilities in financial technology, providing financial licensing resources, digital asset issuance and trading capabilities, as well as expertise in quantum technology [1] Group 2 - Huajian Medical can leverage Guofu Quantum's 22.5% stake in Southern Dongying to collaboratively build a blockchain and financial technology-centric on-chain financial ecosystem [1] - This platform aims to integrate compliant digital architecture with traditional asset forms, promoting asset tokenization, fragmentation, and cross-border flow [1] - The initiative is focused on creating a new type of financial infrastructure [1]
华检医疗午后涨超9% 收购国富量子有望实现协同效应 公司持续推进RWA交易所战略落地